{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:57:16Z","timestamp":1791233836796,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2023.11.005","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T14:33:41Z","timestamp":1703601221000},"page":"S53-S58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S6","title":["Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-9073","authenticated-orcid":false,"given":"Elizete","family":"Negreiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6367-7516","authenticated-orcid":false,"given":"Talita M\u00e1ira","family":"Bueno da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4539-6825","authenticated-orcid":false,"given":"S\u00e9rgio Costa","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-2578","authenticated-orcid":false,"given":"Carlos S\u00e9rgio","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2023.11.005_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.htct.2023.11.005_bib0002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9610(98)00204-9","article-title":"Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer","volume":"176","author":"Nozoe","year":"1998","journal-title":"Am J Sug"},{"key":"10.1016\/j.htct.2023.11.005_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","article-title":"The phenomenon of the acute phase response","volume":"389","author":"Kushner","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.htct.2023.11.005_bib0004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","article-title":"Function of C-reactive protein","volume":"32","author":"Du Clos","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.htct.2023.11.005_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11912-002-0023-1","article-title":"The role of C-reactive protein as a prognostic indicator in advanced cancer","volume":"4","author":"Mahmoud","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.htct.2023.11.005_bib0006","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00006454-199708000-00003","article-title":"Clinical applications of C-reactive protein in pediatrics","volume":"16","author":"Jaye","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.htct.2023.11.005_bib0007","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2023.11.005_bib0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.31096","article-title":"Lower socioeconomic status is independently associated with shorter survival in Hodgkin lymphoma Patients-An analysis from the Brazilian Hodgkin Lymphoma Registry","volume":"142","author":"Biasoli","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.htct.2023.11.005_bib0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S1516-84842010005000089","article-title":"Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil","volume":"32","author":"Britto","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.htct.2023.11.005_bib0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.1982.tb22153.x","article-title":"Serum C-reactive protein levels in disease","volume":"389","author":"Morley","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.htct.2023.11.005_bib0011","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive Protein: a critical update","volume":"111","author":"Pepys","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.htct.2023.11.005_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0032-1323824","article-title":"Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL)","volume":"224","author":"Haase","year":"2012","journal-title":"Klin Padiatr"},{"issue":"4","key":"10.1016\/j.htct.2023.11.005_bib0013","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bjhh.2015.05.003","article-title":"Evaluation correlates C-reactive protein with advanced stage Hodgkin's lymphoma and response to treatment in a tertiary university hospital in Brazil","volume":"37","author":"Rocha","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.htct.2023.11.005_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mpo.10286","article-title":"C-reactive Protein (CRP) as tumor marker in pediatric an adolescent patients with Hodgkin disease","volume":"41","author":"Wieland","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.htct.2023.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2006.08.1331","article-title":"Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the groupe D'etude des lymphomes de L'adulte","volume":"25","author":"Casasnovas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2023.11.005_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3322\/caac.21438","article-title":"Hodgkin Lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.htct.2023.11.005_bib0017","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10552-016-0780-z","article-title":"Estimating the prevalence of hematological malignancies and precursor conditions using data from haematological malignancy research network (HMRN)","volume":"27","author":"Li","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.htct.2023.11.005_bib0018","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.htct.2023.11.005_bib0019","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bjhh.2017.08.001","article-title":"High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center","volume":"39","author":"P\u00e9rez","year":"2017","journal-title":"Rev Bras Hematol Hemoter"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923026044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923026044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:06:28Z","timestamp":1737975988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923026044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"alternative-id":["S2531137923026044"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.11.005","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}]}}